US firm ups offer for UDG Healthcare to £2.7bnImproved and ‘final’ offer from private equity company CD&R prompted by shareholder opposition to ‘opportunistic’ original bid
Largest shareholder in UDG Healthcare hits out at ‘opportunistic’ takeover offerAllianz GI says Clayton, Dubilier & Rice’s offer is ‘opportunistic’ and ‘significantly undervalues’ the business
UDG Healthcare’s Sharp division outperforms its chief executive’s hopesThe contract clinical, manufacturing, packaging and technology services business sees 34 per cent increase in adjusted operating profit